Karyotype modifications in human malignant melanoma cell cultures after treatment with azelaic acid

P. Grammatico, S. Scarpa, M. Picardo, K. Steindl, M. Nazzaro-Porro, G. Del Porto

Research output: Contribution to journalArticle

Abstract

Azelaic acid (AzAc) is a C9 dicarboxylic acid which has recently been shown to have some therapeutic applications in skin diseases of different aetiologies. In order to study the in vitro activity of AzAc five human malignant melanoma primary cell cultures were treated for up to 60 days with 10 mM C9 2Na; the growth characteristics were defined by growth curve and the cytogenetics by Giemsa standard technique and GTG banding technique. Our data demonstrated an inhibition in replication of all five melanomas and the disappearance of the clones with chromosomal markers in four out of five melanomas after AzAc treatment.

Original languageEnglish
Pages (from-to)119-123
Number of pages5
JournalMutation Research/Genetic Toxicology
Volume300
Issue number2
DOIs
Publication statusPublished - 1993

Keywords

  • Azelaic acid
  • Cytogenetics
  • Melanoma

ASJC Scopus subject areas

  • Genetics
  • Toxicology
  • Medicine(all)

Fingerprint Dive into the research topics of 'Karyotype modifications in human malignant melanoma cell cultures after treatment with azelaic acid'. Together they form a unique fingerprint.

  • Cite this